Vergoeding 2017-2021 voor ATC-subgroep N05AX : Overige antipsychotica
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| N05AX08 Risperidon (Risperdal ®) | 5.064.500 | 4.643.700 | 4.611.700 | 4.463.300 | 3.758.000 |
| N05AX12 Aripiprazol (Abilify maintena ®) | 10.797.200 | 10.436.100 | 11.191.100 | 11.732.300 | 11.669.700 |
| N05AX13 Paliperidon (Xeplion ®) | 9.813.800 | 10.571.000 | 11.773.300 | 12.625.400 | 12.661.300 |
| N05AX15 Cariprazine (Reagila ®) | . | 4.180 | 151.150 | 338.960 | 375.240 |
| N05AX16 Brexpiprazol (Rxulti ®) | . | . | 37.899 | 162.690 | 204.900 |
| Totaal | 25.675.500 | 25.654.980 | 27.765.149 | 29.322.650 | 28.669.140 |